·Confidence 90%
Novartis Drug Setback Heightens Competition for Amgen, Eli Lilly
Novartis' recent failure in cholesterol drug development intensifies the competitive landscape for Amgen and Eli Lilly in reducing heart attack risks.
#Biotechnology
2 articles tagged with #Biotechnology
·Confidence 90%
AI Labs Collaborate on Safety Measures for Drug Discovery
Anthropic, OpenAI, and Google DeepMind join forces to establish safety protocols for AI in biology, highlighting the importance of governance in scientific